GlycoErase™ PPP1R3C Knockout HEK293T Cell Line (CAT#: GLJF-0825-JF574)

Description	GlycoErase™ PPP1R3C knockout HEK293T cell line eliminates PPP1R3C, a PP1 subunit that promotes glycogen synthase activation and inhibits phosphorylase. Hypermethylation of this gene has been linked to colorectal cancer. The knockout model enables research on glycogen metabolism, epigenetic control, and cancer metabolism.
Product Type	KO Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:2~1:4
Cell Line	HEK293T
Lineage	Embryonic kidney

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	PCR, Sanger Sequencing
Culture Medium	DMEM & FBS & Penicillin/Streptomycin
Application	Functional assay
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	PPP1R3C
Full Name	Protein Phosphatase 1 Regulatory Subunit 3C
Alternative Name	PTG; PPP1R5
Location	10q23.32
Gene ID	5507
Summary	This carbohydrate-binding PP1 subunit promotes glycogen synthesis by activating glycogen synthase and suppresses glycogen breakdown by reducing phosphorylase activity. DNA hypermethylation of this gene has been observed in colorectal cancer cases.